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Collagen materials have been utilized in medicine and dentistry
because of their proven biocompatability and capability of pro-
moting wound healing. For guided tissue regeneration (GTR)
procedures, collagen membranes have been shown to be com-
parable to non-absorbable membranes with regard to probing
depth reduction, clinical attachment gain, and percent of bone
fill. Although these membranes are absorbable, collagen mem-
branes have been demonstrated to prevent epithelial down-
growth along the root surfaces during the early phase of wound
healing. The use of grafting material in combination with colla-
gen membranes seems to improve clinical outcomes for furca-
tion, but not intrabony, defects when compared to the use of
membranes alone. Recently, collagen materials have also been
applied in guided bone regeneration (GBR) and root coverage
procedures with comparable success rates to non-absorbable
expanded polytetrafluoroethylene (ePTFE) membranes and con-
ventional subepithelial connective tissue grafts, respectively.
Long-term clinical trials are still needed to further evaluate the
benefits of collagen membranes in periodontal and peri-implant
defects. This article will review the rationale for each indication
and its related literature, both in vitro and in vivo studies. The
properties that make collagen membranes attractive for use in
regenerative therapy will be addressed. In addition, varieties of
cross-linking techniques utilized to retard the degradation rate
of collagen membranes will be discussed. J Periodontol 2001;
72:215-229.
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Traditional periodontal surgeries areoften performed to gain access todiseased root surfaces and remove
local factors, i.e., plaque, calculus, and
endotoxin. Periodontal surgical tech-
niques include gingivectomy, open flap
debridement, modified Widman flap, and
osseous surgery, which may offer prob-
ing depth reduction and gain of clinical
attachment.1-3 However, new attachment
achieved by these procedures is usually
a result of the formation of long junc-
tional epithelium with slight or no new
connective tissue attachment and negli-
gible new cementum formation.4-7 In
contrast, guided tissue regeneration
(GTR), the procedure in which a barrier
is utilized to exclude epithelium from the
root surfaces,8 has been shown to par-
tially regenerate lost periodontal tissue
with new bone, periodontal ligament, and
cementum.9 Several materials, both non-
absorbable and bioabsorbable barriers,
have been developed and modified in an
attempt to achieve complete periodontal
regeneration.9 More recently, the mem-
brane barriers have also been applied for
regenerating bone surrounding peri-
implant defects, in the so-called guided
bone regeneration (GBR) procedure.10
The purpose of this article is to address
the uses of collagen membranes for their
roles in GTR, GBR, and other applica-
tions. The properties that make collagen
membranes attractive for use in regen-
erative therapy will be addressed. The
related literature, both in vitro and in vivo
studies, as well as clinical trials will be
discussed. Moreover, a description of how
collagen membranes have been used
clinically and the future role of this mate-
rial in dental treatment will be explored.
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Collagen Membranes and Their Properties
Due to the need for a second surgery to retrieve non-
absorbable membranes, a demand for bioabsorbable
membranes with comparable, if not better, clinical out-
comes became apparent. Type I collagen is a pre-
dominant component found in periodontal connective
tissue. Several commercially available collagen mem-
branes have been developed using type I collagen as
their major component (Table 1). In addition, colla-
gen materials also possess additional advantages
including hemostasis, chemotaxis for periodontal lig-
ament (PDL) fibroblasts11,12 and gingival fibroblasts,13
weak immunogenicity,14-16 easy manipulation, and
ability to augment tissue thickness.17 Hence, collagen
material appears to be an ideal choice for an
absorbable GTR barrier. It should be noted that
although the main component of collagen membranes
discussed in this paper is type I collagen, these mem-
branes are, in fact, not identical depending on sources
of material (bovine or porcine) and additional com-
ponents. However, for the purposes of this review, these
membranes are all considered as collagen membranes,
while details of the components and cross-linking tech-
niques are provided in the tables.
Quteish et al.18 evaluated the biocompatability and
resorption pattern of a human collagen graft mate-
rial both in vitro and in vivo. Human collagen,
extracted from placenta, was implanted subcuta-
neously in 10 Sprague Dawley rats. The graft was
encapsulated by day 7 and was slowly resorbed over
56 days with minimal inflammatory response. Locci
et al.13 compared the degree of biocompatability
between collagen and polytetrafluoroethylene (PTFE).
Using 3H-thymidine, it was found that PTFE mem-
brane inhibited gingival fibroblast DNA synthesis,
while the matrix membrane, consisting of 95% colla-
gen and 5% chondroitin-4-sulfate, enhanced cell pro-
liferation. In addition, the PTFE membrane caused a
marked decrease in synthesis of extracellular colla-
gen and glycosaminoglycan (GAG), the major com-
ponents of extracellular matrix (ECM). Collagen
matrix resulted in a significantly increased produc-
tion of these components. Since ECM plays a major
role in wound healing, the authors proposed that col-
lagen may be more suitable than PTFE barrier to
achieve periodontal regeneration. Schlegel et al.16
evaluated the immune responses to the collagen
membrane both in vivo and in a pilot study in
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Table 1.
Collagen Membranes Currently Available or Under Investigation*
Name Company Sources Methods of Cross-Link Main Components Resorption Rate†
BioMend Sulzer Calcitek, Bovine tendon Formaldehyde 100% type I collagen 6-8 weeks
Carlsbad, CA
BioMend-Extend Sulzer Calcitek, Bovine tendon Formaldehyde 100% type I collagen 18 weeks
Carlsbad, CA
Periogen Collagen Inc., Bovine dermis Glutaraldehyde Types I and III collagen 4-8 weeks
Palo Alto, CA
Paroguide Coletica, Lyon, France Calfskin DPPA‡ 96% type I collagen 4-8 weeks
and 4% chondroitin-
4-sulfate
Biostite Coletica, Lyon, France Calfskin DPPA 88% hydroxyapatite, 4-8 weeks
9.5% type I collagen, and
2.5% chondroitin-4-
sulfate
BioGide Geistlich,Wolhusen, Porcine dermis None Types I and III collagen 24 weeks
Switzerland
Tissue Guide Koken Co.,Tokyo, Bovine dermis + tendon HMDIC§ Atelocollagen (1°) + 4-8 weeks
Japan tendon collagen
BioBar Colbar Research & Bovine tendon N/A 100% type I collagen 6-8 months
Dev. Ltd., Ramat-
Hasharon, Israel
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humans. Using enzyme-linked immunosorbent assay
(ELISA), the authors found no specific immunoreac-
tion against collagen during an 8- to 65-day obser-
vation period. Thus, this confirmed the lack of
immunogenicity of collagen membrane previously
reported by Johns et al.19 and Wang et al.20
The ideal properties of a barrier for GTR procedures
include the ability to exclude unwanted epithelial cells
and maintain a space for appropriate cells (e.g., PDL
cells, bone cells, and/or cementoblasts) to repopulate
the wounded area. Thus, a membrane must maintain
its structural integrity during early wound healing. The
degradation rate of collagen membranes varies
depending on the source. Unsal et al.21 compared dif-
ferent collagen materials including fascia lata, fascia
temporalis, dura mater, and bovine origin. By placing
the collagen materials subcutaneously in rats for up to
42 days, the authors observed that type I bovine col-
lagen and fascia lata were resorbed faster and that the
majority of materials were replaced by normal con-
nective tissue after 42 days. In contrast, the resorption
rates of dura mater and fascia temporalis were much
slower. However, whether this information from an in
vivo study performed subcutaneously could be applied
to the human oral cavity requires further investigation.
Paul et al.22 examined the degradation rate of non–
cross-linked bovine collagen in an attempt to treat
Class II furcation defects. No residual collagen mate-
rial protruding from the gingival margin was noted at
one week. However, Pitaru et al.23 reported a half-life
of 21 to 28 days for non–cross-linked collagen when
implanted intramuscularly or subcutaneously. These
differences in degradation times between these 2 stud-
ies may be attributed to different study designs with
regard to placement site; i.e., intramuscularly or sub-
cutaneous versus intraoral, as well as a closed versus
an open environment. Several periodontal pathogens
(e.g., Porphyromonas gingivalis, Bacteroides melanino-
genicus) have been reported to be capable of pro-
ducing collagenase24,25 that may degrade membranes
prematurely. In addition, it should be noted that Paul
et al.22 intentionally exposed the coronal part of the
collagen membrane. This may allow bacterial colo-
nization, resulting in early degradation and ultimately
compromising the final outcomes.26-28
To prolong the absorption time of collagen mem-
branes, various cross-linking techniques have been
developed. These include ultraviolet light,23,29 hexa-
methylenediisocyanate (HMDIC),29,30 glutaraldehyde
plus irradiation,31 and diphenylphosphorylazide.32,33
Pitaru et al.23 treated surgically created defects in dogs
with cross-linked collagen membranes obtained from
rat-tail tendons. They reported partial regeneration
consisting of new bone, PDL, and cementum in the
apical half, with long junctional epithelium and con-
nective tissue attachment in the coronal half of defects.
However, only long junctional epithelium with negligi-
ble new bone was observed in sites treated with flap
debridement only. The authors attributed partial regen-
eration to early membrane exposure, resulting in quick
degradation of the membrane. Using 250 rats, Minabe
et al.29 studied differences in wound healing between
atelocollagen (purified from bovine dermis) and insol-
uble collagen (purified from bovine tendon) cross-
linked with ultraviolet rays or HMDIC. Two layers of
membrane were placed under palatal flaps in the treat-
ment groups, while flaps were closed without any mem-
brane in the control group. The greatest inhibitory
effect on epithelial downgrowth was observed in the
HMDIC weak cross-linked atelocollagen subgroup
(31.2%). In addition, it was noted that the non–cross-
linked collagen membrane disappeared in 5 to 7 days,
while residues of the cross-linked collagen membrane
were still observed at day 14. The authors concluded
that the higher the degree of cross-linking, the slower
the rate of degradation of the collagen membrane.
Since a non-absorbable (ePTFE) membrane is
required to stay in place for 4 to 6 weeks before being
surgically removed, one may question the effective-
ness of the collagen membrane in enhancing regener-
ation due to its relatively fast degradation rate. Minabe
et al.29 demonstrated that rapid epithelial proliferation
occurred on days 3 to 5, and then progressed up to 14
days in the non–cross-linked collagen group. In contrast,
the rate of epithelial proliferation increased slightly up
to day 5 with no subsequent downgrowth in the cross-
linked atelocollagen group. Similar results were also
obtained by Kodama et al.30 in a 28-day study in 120
Wistar rats. In this study, the effect of collagen con-
centration in HMDIC cross-linked atelocollagen was
evaluated. Regardless of the concentration, collagen-
treated sites demonstrated a significantly slower rate
of apical migration and more perpendicular fiber bun-
dles compared to untreated controls. Thus, from these
studies it may be postulated that the period of time in
which a collagen membrane remains intact is sufficient
for preventing apical migration of epithelium during
early periodontal wound healing, since the critical time
for epithelial proliferation occurs within the first 14 days.
Furthermore, Numabe et al.,34 using 3H-thymidine
autoradiography, observed epithelial cell kinetics dur-
ing periodontal wound healing with and without atelo-
collagen membrane in a rat model. The authors
reported that in the collagen membrane group, 3H-
thymidine labeled cells were noted in both basal and
prickle cell layers of newly formed sulcular epithelium,
compared to only a single layer of 3H-thymidine-incor-
porated basal cells along the root surface in non-mem-
brane treated controls. In addition, there was no apical
extension of the epithelium beyond the cemento-enamel
junction (CEJ) in the collagen group even though the
membrane was completely resorbed at day 14. These
217
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findings implied that the collagen membrane decreases
the mitotic activity of basal cells resulting in piling up
of dividing cells adjacent to the membrane, thus inhibit-
ing apical migration of the epithelium. Although these
reports showed an adequate barrier function of the col-
lagen materials, it is noteworthy that most studies were
conducted in a rat model in a short period of time. Fur-
ther studies in this area are still needed.
It should be noted that a prolonged resorption rate
of the collagen membrane does not always result in
greater periodontal/bone regeneration. Using rat cal-
varial defects, Brunel et al.32 evaluated the effect of
degrees of cross-linking on guided bone regeneration.
Their results confirmed previous reports that the higher
degree of cross-linking, the longer the resorption rate,
and more defect fills were noted on membrane-treated
sites. However, no statistically significant differences in
bone fills were observed among sites treated with col-
lagen membranes with different cross-linking degrees.
Interestingly, highly cross-linked, slow-resorbing colla-
gen membranes appeared to have negative effects on
final clinical outcomes as reported by Crigger et al.35
in a dog model. The authors found the greatest attach-
ment gain when using weak cross-linked, rapid-resorb-
ing collagen membranes, followed by ePTFE mem-
branes and high cross-linked collagen membranes.
Membrane exposure, one of the primary contributing
factors for GTR/GBR failure, was commonly found in
ePTFE membranes and highly cross-linked collagen
membranes. At 6 months, the highly cross-linked mem-
brane group demonstrated extensive recession and loss
of attachment. In contrast, the weak cross-linked col-
lagen showed 84% new connective tissue attachment
while ePTFE membranes had only 53%.
Regarding cross-linking techniques, the glutaralde-
hyde technique, the most widely used chemical cross-
linking technique, was reported to leave cytotoxic
residue during the process.36 To overcome the draw-
back of this technique, the diphenylphosphorylazide
(DPPA) technique was developed. Collagen barriers
manufactured through this process showed compara-
ble results when compared to other collagen mem-
branes.33
In addition to cross-linking, heparan sulfate and
fibronectin have also been added in an attempt to
enhance the inhibitory effect on epithelial migration.
In a dog model, Pitaru et al.37 compared the length of
the root surfaces repopulated by connective tissue
between sites treated with collagen membrane alone,
and those treated with a fibronectin and heparan sul-
fate-enriched collagen membrane. Approximately 30%
more root surfaces were repopulated with connective
tissue in the fibronectin and heparan sulfate-treated
group compared to the collagen alone group.
Overall, studies have shown that collagen materials
have an ability to inhibit apical migration of epithe-
lium regardless of the fast degradation rate. It should
be noted that once the epithelium becomes mature,
membrane integrity is no longer essential for tissue
regeneration. Hence, the crucial period for the mem-
brane to remain intact is during the early wound heal-
ing period when the epithelium actively migrates along
the root surface.38 After that, the presence of a bar-
rier may cause a delay in connective tissue matura-
tion during the late phase of wound healing.
Animal Studies
Several animal studies have been conducted to eval-
uate the safety and efficacy of collagen barriers (Table
2). Most earlier studies focused on collagen biocom-
patibility and its resorption rate,12,13,16,29,30,34 and the
majority of them used surgically created defects. In
addition, most studies ended within 4 to 12 weeks,
with few studies lasting for 6 months. These factors
should be considered when applying results obtained
from these in vivo reports. Nevertheless, the conclu-
sions drawn from these animal studies can be used as
a reference for the material. They are: 1) collagen
membranes are weak immunogen and biocompatible;
2) collagen membranes possess the chemotactic abil-
ity to attract gingival and/or PDL fibroblasts, thus pro-
moting proliferation and extracellular matrix matura-
tion, and facilitating wound healing;13,16 3) collagen
membranes have been shown to be an effective bar-
rier in preventing apical migration of epithelium;29,30,34
4) the higher degree of cross-linking, the slower the
resorption rate;29-33,35 and 5) collagen membranes
provide better clinical results when compared to open
flap debridement alone.23,35,37,39,40
Guided Tissue Regeneration
Intrabony defects. Since the late 1980s, collagen
membranes have been tested for their ability to pro-
mote regeneration in periodontal intrabony defects
(Table 3).31,41-46 Most studies have shown significantly
greater probing depth (PD) reduction, clinical attach-
ment gain, and bone fill in collagen-treated groups
than open debridement controls.31,42-45 The mean PD
reduction from these studies ranged from 3.1 to 5.5
mm in collagen-treated groups, while only 2.2 to 2.8
mm reductions were noted in controls. However, Tan-
ner et al.41 showed no difference in clinical attach-
ment gain when comparing collagen membranes to
flap debridement alone. It should be noted that this
study was done in only 4 patients with hopeless teeth,
and results were obtained only at 3 months. Other
studies had more participants (9 to 52) with longer
follow-up (6 months). Factors contributing to these
variable results include different cross-linking tech-
niques, initial probing depths, width of defects, mea-
suring techniques, and different analytical methods.47
For example, Chung et al.42 used mean PD and attach-
ment level from each tooth for data analysis instead
218
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of those of the actual intrabony defects. With this ana-
lytical approach, little or no improvement from shal-
low PD sites may mask the actual improvement
observed on the treated defect sites. Therefore, it is not
surprising that the results from this study showed less
attachment level gain than other studies. Neverthe-
less, the majority of these studies showed significantly
greater clinical improvements when collagen mem-
branes were used.
Parodi et al.48 reported a human histological biopsy
of a mesial circumferential defect on a maxillary molar
treated with DPPA cross-linked collagen membrane
containing 4% chondroitin-4-sulfate. At 5 months, a
clinical attachment gain of 4 mm was observed. His-
tological observation demonstrated highly vascular-
ized periodontal ligament, and new cementum with
an active cementoblast front and new bone formation
up to the crestal level. Moreover, no sign of inflam-
mation was noted. It was concluded that collagen
membranes can enhance partial periodontal regener-
ation in humans. Evans et al.49 used meta-analysis to
analyze GTR articles published between 1994 to early
1996. The mean PD reduction and CAL gain with a
GTR procedure utilizing collagen membranes were 4.1
mm and 4.0 mm, respectively. These results were
comparable to those of studies using ePTFE mem-
220
Table 3.
Collagen Membrane in Treating Intrabony Defects in Humans
Mean Initial Mean PD Mean CAL Defect Fill 
Reference N (mean age) Collagen Type Study Length Treatment Groups PD (mm) Reduction (mm) Gain (mm) (%)
Chung et al. 15 patients Cross-linked bovine 12 months Split-mouth design
199042 (21–39 years) type I collagen (reentry) 1) Flap 5.4 ± 1.9 NA –0.7 ± 0.9 N/A
with 20 debridement
paired defects 2) Collagen 6.0 ± 2.2 N/A 0.6 ± 0.6 N/A
membrane NS P <0.01
Quteish and 19 patients Irradiated 6 months Split-mouth design
Dolby (N/A) with glutaraldehyde 1) Flap 5.8 ± 1.4 2.2 2.3 N/A
199231 52 matched human type I debridement
defects collagen extracted 2) Collagen 6.4 ± 1.9 4.2 4.0 N/A
from placenta membrane NS P <0.0001 P <0.0001
al-Arrayed 14 patients Cross-linked human 6 months Split-mouth design
et al. (43.7 years) type I collagen 1) Open flap 6.4 2.8 3.7 N/A
199543 debridement
2) Collagen 6.7 4.3 3.9 N/A
NS P <0.05 P <0.05
Mattson et 9 patients Type I bovine 12 months Split-mouth design,
al. 199544 (49.7 years) collagen (reentry) but not balanced 
for severity
1) Open flap 6.6 ± 1.2 2.2 ± 1.8 0.4 ± 2.0 28
debridement
2) Collagen 7.2 ± 0.9 3.1 ± 1.6 2.4 ± 2.1 77
Benquét et 52 AP patients DPPA cross-linked 6 months One defect/patient
al. 199745 and 16 RPP bovine type I 1) Adult 9.6 ± 2.0 5.5 ± 2.4 3.6 ± 2.2 N/A
patients collagen periodontitis
2) RPP 8.3 ± 1.6 4.1 ± 2.6 2.6 ± 3.0 N/A
Mattson 19 patients Cross-linked 6 months
et al. (50.4 years) bovine tendon (reentry) 1) Collagen 6.18 ± 0.9 3.27 ± 1.91 2.58 ± 1.9 2.15 ± 2.0
199946 with at least (type I collagen) membrane 
one 2- to 3- (n = 11)
walled 2) PGA/PLA 
interproximal copolymer 6.14 ± 2.02 3.55 ± 2.47 2.77 ± 2.13 1.9 ± 1.9
defect membrane 
(n = 12) NS NS NS NS
RPP—rapidly progressive periodontitis.
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branes (5.1 mm and 3.6 mm, respectively). The
authors also reported that there were no statistically
significant differences in clinical outcomes among var-
ious GTR membranes (ePTFE, collagen, collagen plus
bone graft, polylactic acid/polyglycolic acid copoly-
mer [PLA/PGA], and rubber dam). However, it should
be remembered that even with the best results ever
reported, none of these studies demonstrated a com-
plete fill of periodontal defects.
Combined Use of Collagen Membrane and Other
Materials
Several attempts have been made to enhance regen-
eration outcomes by combining/adding other materi-
als. These include a combination of collagen mem-
branes and bone grafting materials, metronidazole-
impregnated collagen, fibronectin and heparan sulfate-
enriched collagen, and a combination of collagen
membrane and collagen gel (Table 4).37,50-53 These
techniques mainly aim to provide space maintenance
and to recruit cells with regenerative potential. It is
believed that bone grafting materials not only maintain
the space, but also provide an osteoinductive and/or
osteoconductive capacity. In 1990, Blumenthal and
Steinberg50 reported statistically significant improve-
ment in defect fill with the use of freeze-dried bone
and microfibrillar collagen gel‡ in addition to collagen
barrier. However, it should be noted that this study was
conducted in only 10 patients (71 defects) with 5 dif-
ferent treatment groups. Also, the original PD or
description of defect morphology is lacking. Chen et
221
‡ Zyderm, Collagen Corp., Palo Alto, CA.
Table 4.
Combined Use of Collagen Membrane and Other Materials in Humans
Mean Initial Mean PD Mean CAL Defect Fill 
Reference N (mean age) Collagen Type Study Length Treatment Groups PD (mm) Reduction (mm) Gain (mm) (%)
Blumenthal 10 patients Purified bovine 12 months 1) Open N/A 1.5 ± 0.2 0.8 ± 0.2 5.9 ± 1.5
and (34–57 years) collagen, allogenic (reentry) debridement
Steinberg with 71 defects freeze-dried bone 2) Membrane alone N/A 2.0 ± 0.1 1.2 ± 0.1 30.6 ± 2.8
199050 & microfibrillar 3) Bone graft alone N/A 2.0 ± 0.1 1.4 ± 0.1 47.7 ± 2.7
collagen gel 4) Bone and N/A 2.6 ± 0.1 1.9 ± 0.2 48.5 ± 3.5
collagen gel
5) Bone, collagen N/A 2.7 ± 0.1 2.0 ± 0.1 62.7 ± 2.5
gel, and membrane
Dowell  16 patients Cross-linked human 6 months Split-mouth design
et al. (43.7 ± 4 type I collagen 1) Collagen 6.8 4.3 ± 0.9 NS N/A
199551 years) with with or without membrane
78 bilateral metronidazole 2) Metronidazole- 6.7 4.3 ± 0.9
defects (8 mg/cm2) impregnated
collagen NS NS
Chen 10 patients Cross-linked 6 to 12 months Split-mouth design
et al. (26–62 years) bovine tendon (reentry) 1) Collagen 7.4 ± 0.4 3.2 ± 0.4 2.0 ± 0.4 39.6
199552 with bilateral with or without membrane
defects DFDBA 2) Collagen 7.6 ± 0.4 3.4 ± 0.4 2.3 ± 0.5 35.4
membrane with
DFDBA NS NS NS NS
Benqué 43 AP patients DPPA cross-linked 6 months One defect/patient
et al. (49.2 ± 9.9 bovine type I 1) AP patients 9.5 ± 2.0 6.1 ± 2.1 4.2 ± 2.1 N/A
199753 years) and 14 collagen with or 2) RPP patients 8.2 ± 1.8 4.7 ± 1.2 3.0 ± 1.6 N/A
RPP patients without P <0.05 P <0.05
(38 ± 4.7 hydroxyapatite/
years) with collagen/
deep 2-wall chondroitin 
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al.,52 in a randomized split-mouth design clinical trial,
showed that demineralized freeze-dried bone allograft
(DFDBA) had no additional benefit to the GTR ther-
apy with collagen membrane alone. The use of graft-
ing material containing hydroxyapatite, collagen, and
chondroitin-sulfate§ in addition to the collagen mem-
brane was also studied by Benqué et al.53 The authors
attempted to treat 2-wall intrabony defects in both
chronic adult periodontitis and rapidly progressive peri-
odontitis patients. The results indicated that this com-
bined technique significantly improved PD and CAL in
both patient groups. In addition, there were statisti-
cally significant greater PD reduction and CAL gain in
chronic adult periodontitis patients than rapidly pro-
gressive periodontitis patients. However, this study
lacked a negative control (open debridement), positive
control (membrane alone), and placebo control (mem-
brane plus gel carrier) groups; therefore, it is incon-
clusive whether the spacer or its components
accounted for the improvement.
In addition to space maintaining materials, antibi-
otic-impregnated collagen membranes have also been
utilized to reduce the risk of bacterial contamination.
Dowell et al.,51 in a double-blinded, randomized, split-
mouth design clinical trial, failed to demonstrate the
extra benefit of metronidazole-impregnated collagen
over the collagen membrane alone.
Class II furcation defects. It is generally agreed
that treatment of furcation defects is more compli-
cated and challenging than that of non-furcated
222
Table 5.
Collagen Membrane in Treating Class II Furcation Defects in Humans
Collagen Type
Results
% CI II 
& Additional Study Initial Initial V-Defect H-Defect → Cl I 
Reference N (mean age) Materials Length Treatment Groups V-Depth H-Depth Fill Fill Defects
Paul et al. 7 patients (51.7 Type I bovine collagen 6 months Split-mouth design
199222 years) with bilateral (reentry) 1) Flap debridement 6.1 ± 1.8 3.9 ± 2.1 0.4 ± 0.8 0.0 ± 0.9 N/A
defects 2) Collagen membrane 6.4 ± 1.9 4.7 ± 2.0 0.7 ± 0.9 0.9 ± 0.9
NS NS NS P <0.05
Van Swol 38 patients (31–71 Chemical cross-linked 3 months One defect/patient >50% H-Fill
et al. years) purified bovine (reentry) 1) Flap debridement 7.1 ± 1.6 5.7 ± 2.5 0.7 0.7 0/10
199360 dermal collagen (10)
2) Collagen membrane 6.9 ± 1.6 5.1 ± 1.4 1.7 2.3 5/28
(28)
NS NS P <0.05 P <0.0001
Blumenthal 12 patients (31–80 Chemical cross-linked 12 months Split-mouth design
199362 years) with paired purified bovine (reentry) 1) ePTFE membrane 6.2 ± 2.2 4.9 ± 0.7 1.0 ± 1.0 1.7 ± 0.5 N/A
buccal Class II dermal collagen 2) Collagen membrane 7.00 ± 2.2 5.3 ± 1.3 1.6 ± 1.2 2.5 ± 0.7
mandibular molar NS NS NS P <0.05
furcation defects
Black et al. 13 patients (43.2 Cross-linked bovine 6 months Split-mouth design
199463 years) with a pair tendon type I collagen 1) ePTFE membrane 5.3 ± 1.6 4.3 ± 2.0 1.1 ± 0.8 0.8 ± 2.2 N/A
of comparable Class 2) Collagen membrane 5.00 ± 1.8 4.4 ± 1.5 1.4 ± 1.7 1.5 ± 2.0
II molar defects NS NS NS
Wang 12 patients (46.4 Cross-linked type I 12 months Split-mouth design >50% H-Fill
et al. years) with bilateral bovine collagen (reentry) 1) Flap debridement 4.2 ± 2.2 5.6 ± 2.7 1.5 ± 0.3 1.1 ± 0.6 4/12
199420 mandibular 2) Collagen membrane 4.2 ± 1.7 6.0 ± 2.7 2.8 ± 0.4 2.0 ± 0.4 3/12
furcation defects NS NS P <0.05 NS
Yukna and 59 patients (46.8 Type I bovine tendon 6 to 12 Split-mouth design % improved
Yukna years) from 7 collagen months 1) Flap debridement 3.2 ± 1.6 5.3 ± 2.0 0.8 ± 1.5 1.1 ± 2.0 defects
199664 centers (mean (27)
11.1) Collagen membrane 3.6 ± 1.7 5.0 ± 2.0 1.7 ± 1.6 2.0 ± 1.7 7
(reentry) (27)
2) ePTFE membrane 1.9 ± 2.5 4.3 ± 1.7 N/A 1.7 ± 2.2 44
(32)
Collagen membrane 1.3 ± 1.0 4.7 ± 1.6 N/A 1.7 ± 1.9 53
(32)
§ Biostite, Coletica Corp., Lyon, France.
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defects because of the complexities of tooth anatomy
including root concavities,54 cervical enamel projec-
tions,55 bifurcation ridges,56 accessory canals,57 and
small entrance access.58 Nonetheless, attempts have
been made to regenerate lost periodontium in furca-
tion defects through varieties of approaches. Table 5
lists studies that have utilized collagen membranes to
promote regeneration in furcated molars. In 1988,
Garrett et al.59 used a collagenous membrane, freeze-
dried dura mater, for treating furcation-involved teeth.
The results, however, showed less favorable outcomes
than coronally positioned flaps with allograft-treated
sites. Paul et al.22 showed minor improvement in hor-
izontal defect fill, with no difference in vertical bone
fill when comparing a collagen membrane-treated
group to an open debridement control group. In con-
trast, Van Swol et al.60 and Wang et al.20 reported
significantly greater defect fills in a collagen-treated
group than an open debridement control group. This
may be explained by the differences in the protocol;
i.e., collagen membranes were intentionally left
supragingivally in the former study while primary cov-
erage was attempted in the latter studies. Since pri-
mary coverage is a key factor in periodontal regen-
eration and premature membrane exposure often leads
to bacterial colonization and compromised clinical
outcomes,26,28,61 it is possible that the unfavorable
outcomes from Garrett et al.59 and Paul et al.22 were
partly the consequences of exposed membranes.
When comparing the use of collagen material to non-
absorbable ePTFE membrane, comparable clinical
results were noted in treating Class II furcation
defects.62-64 Nevertheless, it should be noted that only
14% of these treated sites showed complete furcation
fill.64 Hence, further studies or attempts are still
needed to identify the best methods/materials for fur-
cation defect regeneration/repair.
Root Coverage Procedures
Different techniques have been used to replace lost,
damaged, or diseased gingival tissues. Traditionally,
multiple procedures are often needed to achieve opti-
mal esthetic results. These include lateral pedicle graft,
free gingival graft, and subepithelial connective tissue
graft. However, these procedures often require a sec-
ond surgical site for harvesting grafts, and may cause
postsurgical bleeding and patient discomfort. Recently,
attempts have been made to achieve root coverage
223
Table 6.
Collagen Membrane in Root Coverage Procedures
Results
Mean Initial Gain in Mean Root Mean % % Sites With 
N (mean Study Recession CAL Coverage Root Complete 
Reference age) Collage Type Length Defect Type Depth (mm) (mm) (mm) Coverage Coverage
Shieh et al. 10 patients Cross-linked type I 6 Miller Class I or II buccal 3.2 ± 0.3 1.3 ± 0.5 1.7 ± 0.2 51.6 ± 6.8 10
199774 (40.7 years) bovine collagen months marginal tissue P <0.05 P <0.05 P <0.05
recession ≥ 2.5 mm
Zahedi 15 patients DPPA cross-linked 24 Miller Class I 3.7 ± 1.4 3.5 ± 1.3 2.9 ± 1.1 82.2 ± 23.2 53
et al. (46.7 years) bovine 96% type I months P <0.0001 P <0.0001
199875 collagen with 4%
chondroitin-4-sulfate
Özcan 10 patients Tutoplast fascia 6
et al. (38.5 years) temporalis months 1) Coronally positioned flap 4.1 2.9 2.8 68.6 N/A
199776 with 28 2) Collagen membrane, 4.3 4.2 3.1 71.7 N/A
Miller’s Class I fibrin/fibronectin and P <0.001 NS NS




Wang 16 patients Newly designed 6 Split-mouth design
et al. (40.6 years) double-thickness months 1) Subepithelial 3.4 ± 1.0 2.3 ± 1.0 2.8 ± 0.8 84 ± 25 43.7
199977 with paired membrane connective tissue graft
Miller’s Class I (bovine tendon) 2) Newly designed 3.7 ± 1.1 2.8 ± 0.7 2.5 ± 0.7 73 ± 26 43.7
or II (≥3 mm collagen membrane NS NS NS NS NS
recession 
depth) defects
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using surgical techniques based on the principles of
GTR.65-68 Similar results were reported when GTR-
based techniques were compared to traditional root
coverage procedures.69-72 However, GTR therapy offers
an additional benefit through its potential of achieving
new attachment formation along the previously
denuded root surface, while it rarely occurred when a
subepithelial connective tissue graft was utilized.73
Collagen membranes have recently been used in
root coverage procedures (Table 6). While Shieh et
al.74 gained 51.6% root coverage after 6 months,
Zahedi et al.75 reported mean root coverage of 82.2%
after 2 years. Since neither of these studies included
a control group, it is inconclusive if the GTR-based
procedure is comparable to the conventional proce-
dures. In 1997, Özcan et al.76 compared the use of col-
lagen membranes containing fibrin/fibronectin plus
tetracycline root conditioning to coronally positioned
flaps. They reported no significant differences between
groups with regard to mean root coverage. However,
significantly more gain in clinical attachment was found
in the collagen membrane group compared to the
coronally positioned flap (4.21 mm versus 2.86 mm).
Wang et al.77 compared a conventional subepithelial
connective tissue graft to a GTR-based procedure using
a newly designed double-thickness collagen mem-
brane (prepared from cross-linked bovine tendon and
supplied in individual 20 × 15 × 0.4-0.5 mm pieces)
in 16 patients with bilateral Miller’s Class I or II (gin-
gival recession ≥3.0 mm) recession defects. Data from
this study indicated that the GTR-based procedure
resulted in statistically significant (P <0.05) improve-
ments in recession depth, CAL, and width of kera-
tinized and attached gingiva compared to baseline.
Moreover, the results were comparable to those
achieved from subepithelial connective tissue grafts,
with mean root coverage of 73% and 84% for the newly
designed collagen membrane and conventional con-
nective tissue graft, respectively. Recently, Kimble et
al.78 studied the effect of adjunctive bone graft place-
ment during GTR-based root coverage procedures.
Twenty patients with a Miller Class I or II buccal reces-
sion defect ≥2.5 mm were randomly treated with either
type I collagen membrane alone or type I collagen
membrane plus DFDBA. Preliminary results from this
study indicated both forms of treatment resulted in
statistically significant (P <0.05) reduction of reces-
sion depths (69% for membrane alone and 79% for
membrane plus DFDBA). It was concluded that there
is a tendency for an additional benefit of bone graft for
percent root coverage; however, no statistically sig-
nificant difference was found between groups.
In summary, data from available resources indicate
that GTR-based procedures and subepithelial con-
nective tissue grafts are clinically equivalent. In addi-
tion, using a barrier may also enhance more clinical
attachment gain.76 It should also be noted that with
the GTR-based procedure, adequate flap thickness
(≥0.5 mm in the defect area) seems to have a great
influence in improving the percent root coverage as
reported by Harris70 (26.7% versus 95.9% root cov-
erage in thin and thick tissue, respectively). Therefore,
careful case selection is crucial for the success of this
procedure.
Guided Bone Regeneration (GBR)
Implants have slowly emerged as an alternative pro-
cedure for replacing missing teeth. Ridge deficiency
or inadequate bone height/width often compromises
the overall treatment plan. Bone augmentation using
GTR principles has become a common means to
resolve these concerns. Studies have reported success
in using barriers to augment bone prior to or after
implant placement.79 When selecting an ideal mate-
rial for GBR, the following requirements must be con-
sidered: wound stabilization, space creation and main-
tenance, protection of the underlying blood clot, and
the ability to exclude unwanted tissues or cells (con-
nective tissue and epithelium). Since collagen mem-
branes fulfill all these criteria, it has become one of
the materials used in GBR procedures. However, the
fast resorption rate of collagen material remains a con-
cern to most clinicians. So far, no study has defined
the actual time needed for GBR barriers. Iglhaut et
al.80 reported that during GTR procedures, bone and/or
PDL cell migration reach their peaks in 2 to 7 days after
surgery, with a decrease in mitotic activity to almost
normal levels by the end of the third week. It could be
implied that cells needed for regeneration arrive at the
wound sites in around 3 to 4 weeks; therefore, the
length of time that the collagen membrane retains its
integrity should be sufficient to allow selective cell
repopulation.
GBR procedures utilizing collagen membranes have
been widely reported (Table 7).81-85 In a pilot study,
Colangelo et al.81 created through and through defects
on the lateral aspect of rabbit mandibles and then
treated these defects with either a collagen membrane
or no-treatment control. The histologic evaluation at 30
days demonstrated a nearly complete continuous layer
of lamellar bone with osteoblastic activity in the col-
lagen membrane-treated group compared to only
fibrous connective tissue in the control group. Sevor
et al.82 created buccal dehiscence defects after place-
ment of a total of 48 implants (24 hydroxyapatite [HA]-
coated and 24 grit-blasted) in 6 dogs. At 8 weeks, the
mean defect fill was 80.29% in the collagen mem-
brane-treated group compared to 38.62% in the con-
trol group.
Contrary to the GTR procedures, additional bone
grafting materials for space creation/maintenance tend
to improve GBR outcomes. This was supported by
224
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Table 7.
Collagen Membrane in Guided Bone Regeneration Procedures
Results 
Reference Model (n) Collagen Type Study Length Treatment Groups Clinical and Histologic Observations
Sevor  Mongrel dogs Highly cross- 1 and 2 months Randomly assigned % Defect Fill at 4 Weeks % Defect Fill at 8 Weeks
et al. with linked collagen HA-coated implants 
199382 surgically (24)
created 1) No treatment 47.11 ± 23.13 32.66 ± 17.61
buccal 2) Collagen 83.13 ± 3.32 81.80 ± 6.11
dehiscence membrane
defects Grit-blasted implants 
(6 sites/dog) (24)
1) No treatment 1.02 ± 75.12 44.58 ± 28.73
2) Collagen 55.18 ± 28.34 78.79 ± 21.70
membrane
P <0.007
Colangelo Rabbits with Cross-linked bovine 1 month
et al. 3 x 9 mm tendon type I 1) No treatment 1) The defects were filled with fibrous CT.
199381 defects on collagen control (3) 2) Layer of lamellar bone was noted with osteoblastic 
the lateral 2) Collagen activity.
aspect of the membrane (12)
mandible (15)
Zitzmann 84 exposed Porcine collagen 24 months Split-mouth design Mean % Bone Fill
et al. implant types 1 and III 1) ePTFE 78%





Parodi Patients (mean Calfskin collagen 7 to 12 Native collagen 75% of the defects demonstrated sufficient width for 
et al. age 44.8  (96%) with 4% months sponges were implant placement. Mean increase in the size of the crest 
199888 years) with chondroitin-4- used to maintain was 2.5 mm (3 to 5.5 mm).
insufficient sulfate the space buccally 
ridge (width and lingually.The 
<5 mm) membranes were
(16) placed to cover 
the sponges.
Hürzeler Monkeys Calfskin collagen 6 months Bone/implant contact
et al. (Macaca (96%) with 4% 1) Collagen 2.2 ± 0.9 mm
199883 fascicularis) chondroitin-4- membrane
with  sulfate 2) Collagen 3.3 ± 1.9 mm
surgically membrane and 
created BioOss
defects 3) ePTFE 3.9 ± 1.4 mm
(4 x 4–5 x membrane and 
20 mm) (5) BioOss
4) No membrane control 1.4 ± 0.7 mm
P <0.05 between 1, 4 and 2, 3
Dongieux Mongrel dogs Cross-linked 2.5 months Split-mouth design Initial Graft Volume Final Graft Volume Final: Initial  Volume
et al. received 6 bovine type I (2 for each group (ml) (ml) Ratio
199884 monocortical collagen in each animal)
onlay grafts  1) Onlay graft alone 0.15 ± 0.02 0.06 ± 0.04 0.40
on the 2) Onlay graft with 0.18 ± 0.03 0.06 ± 0.06 0.32
mandibles ePTFE membrane 0.16 ± 0.03 0.07 ± 0.06 0.46
(4) 3) Onlay graft with NS NS NS
collagen membrane
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Hürzeler et al.83 The authors reported collagen mem-
brane combined with bovine HA significantly enhanced
bone-to-implant contact when compared to collagen
membrane alone, or non-membrane treated control
groups. In addition, the results were comparable to
those in the ePTFE membrane plus bovine HA group.
This was further confirmed by Zitzmann et al.86
Collagen membranes have been reported to be
superior to non-absorbable membranes with regard to
healing. Also, a higher incidence of dehiscence, mem-
brane exposure, and/or premature membrane removal
was noted in non-absorbable membranes.81,82,86 Sim-
ilar to GTR procedures, membrane exposure has a
negative impact on the amount of bone regenerated in
GBR. Simion et al.87 reported significantly less bone
gain when the membranes were exposed compared to
non-exposed membrane treated sites (41.6% versus
96.6%).
Collagen sponges have also been placed beneath
collagen membranes to provide space needed for new
bone formation. Parodi et al.88 used collagen mem-
branes combined with a collagen sponge to correct 16
cases with insufficient ridges (<5 mm in width). After
7 to 12 months, 75% of the sites demonstrated suffi-
cient bone volume for implant placement with the
mean increase in crestal bone of 2.49 mm. Recently,
monocortical onlay grafts were introduced to augment
bone prior to implant placement. Dongieux et al.84
evaluated the necessity of barrier membranes in addi-
tion to onlay grafts in a dog model. This 10-week split-
mouth design demonstrated that neither ePTFE mem-
branes nor collagen membranes have an extra benefit
to the onlay graft alone.
To date, the factors that influence bone regeneration
are complex and not yet fully understood. Bone regen-
eration utilizing collagen membranes seems promising.
It should also be noted that the available data are from
studies within the 1990s. Long-term studies are needed
to confirm the success rate of implants placed in regen-
erated bone.
CONCLUSION
In conclusion, collagen membranes have been used
in both medical and dental (especially periodontal)
fields for decades. The benefits of utilizing this
absorbable material include promoting wound healing
through clot stabilization, wound stability, and hemo-
stasis; enhancing primary wound coverage via its
chemotactic ability to attract fibroblasts; and aug-
menting flap thickness by providing a collagenous scaf-
fold. Cross-linked membranes allow a slower degra-
dation rate, therefore providing more time for selective
cells to repopulate the wound areas. Generally, colla-
gen membranes have been proven to significantly
enhance periodontal regeneration in various animal
studies and human clinical trials; however, none of
these studies has shown a complete regeneration. In
addition, collagen membranes have been applied to
guided bone regeneration and root coverage proce-
dures with comparable success rates to non-absorbable
ePTFE membranes and conventional subepithelial con-
nective tissue grafts, respectively. More research is
necessary to improve clinical outcomes and achieve
true periodontal regeneration. A better understanding
of the factors orchestrated in the regeneration process
is required to achieve 100% predictable outcomes in
treating osseous defects around both teeth and
implants.
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